Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance Find Stocks Now
Close

Alkermes Plc (ALKS)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Alkermes Plc's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
24.53 +0.27    +1.11%
14:46:18 - Real-time Cboe. Currency in USD ( Disclaimer )
Type:  Equity
Market:  United States
  • Volume: 655,519
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 24.26 - 24.80
Alkermes Plc 24.53 +0.27 +1.11%

Alkermes Plc Company Profile

 
Get an in-depth profile of Alkermes Plc, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryBiotechnology & Medical Research
SectorHealthcare
Employees

2280

Equity Type

ORD

Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in therapeutic areas in the United States, Ireland, and internationally. It has a portfolio of proprietary commercial products for the treatment of alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder and a pipeline of clinical and preclinical product candidates in development for neurological disorders. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ARISTADA INITIO for the treatment of schizophrenia in adults; VIVITROL for the treatment of alcohol and prevention of opioid dependence; and LYBALVI, an oral atypical antipsychotic drug candidate for the treatment of adults with schizophrenia and bipolar I disorder. It has collaboration agreements primarily with Janssen Pharmaceutica N.V., Janssen Pharmaceutica Inc, and Janssen Pharmaceutica International. The company also offers proprietary technology platforms to third parties to enable them to develop, commercialize, and manufacture products. Alkermes plc was founded in 1987 and is headquartered in Dublin, Ireland.

Contact Information

Address Connaught House 1 Burlington Road
Dublin 4 Dublin, D04 C5Y6
Ireland
Phone 353 1 772 8000
Fax -

Top Executives

Name Age Since Title
Richard F. Pops 61 1991 Chairman & CEO
Nancy L. Snyderman 70 2016 Independent Director
Cato T. Laurencin 64 2021 Independent Director
Emily Peterson Alva 48 2021 Independent Director
David Antonio Daglio 56 2020 Independent Director
Christopher I. Wright 57 2022 Independent Director
Nancy S. Lurker 67 2024 Independent Director
Frank Anders Wilson 65 2019 Lead Independent Director
Shane Martin Cooke 62 2011 Independent Director
Richard B. Gaynor 73 2019 Independent Director
Brian P. McKeon 62 2020 Independent Director
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

ALKS Comments

Write your thoughts about Alkermes Plc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Lisa Solomon
Lisa Solomon Aug 24, 2022 12:31PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Dublin-based Alkermes may not be one of the top biotech stocks that stand out to U.S. investors, open ur eyes ppl
Carlos Andres
Carlos Andres Dec 23, 2021 6:42AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Any recommendation to buy?
Kaushal Shah
Kaushal Shah Dec 16, 2020 8:52PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Why again going down ??
Amit Dave
Amit Dave Dec 16, 2020 8:52PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
No reason to go up for next 3 months. Buy at 19 -19.10..stay long
Wojciech Stefaniak
Wojciech Stefaniak Mar 17, 2020 1:11PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Why again getting into sh... somebody there?
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email